Quantcast

Latest Cyclodextrin Stories

2014-07-23 23:18:14

Investment builds company strength in preparation for clinical trials. Alachua, Fla. (PRWEB) July 22, 2014 CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer and distributor of cyclodextrins for the pharmaceutical, medical device, cosmetics, and other markets, announced today that it has closed on a Private Placement with a group of qualified private investors led by Novit L.P., an investment arm of U.S. Pharmacia. The transaction involved the signing of a Securities Purchase Agreement...

2014-07-09 23:04:12

Dr. Jeffrey Tate promoted to CEO; C.E. Rick Strattan to serve as Executive Chairman. Alachua, FL (PRWEB) July 09, 2014 CTD Holdings, Inc. (OTCQB:CTDH), a distributor and manufacturer of cyclodextrin products including the orphan drug designated Trappsol(R) Cyclo(TM), today announced the promotion of Dr. Jeffrey Tate to Chief Executive Officer, following the retirement of C.E. Rick Strattan. Dr. Tate will hold the titles of President and CEO of CTD Holdings, Inc.; Mr. Strattan will become...

2014-06-05 23:14:01

Dr. Jeffrey Tate will chair 2016 event to be held in Gainesville, Fla. Alachua, Fla. (PRWEB) June 05, 2014 CTD Holdings, Inc. (OTCQB: CTDH), a distributor and manufacturer of cyclodextrin products including the orphan drug designated Trappsol(R) Cyclo(TM), today announced that President and Director Dr. Jeffrey Tate has been named Chairman of the 18th International Cyclodextrin Symposium to be held in Gainesville, Fla. in 2016. The Symposium Advisory Board reviewed three proposals to host...

2014-05-22 23:15:27

Newly created Board positions will focus on corporate governance and capital markets programs. Alachua, FL (PRWEB) May 22, 2014 CTD Holdings, Inc., a distributor and manufacturer of cyclodextrin products including the orphan drug designated Trappsol(R) Cyclo(TM), (OTCQB: CTDH) announced that its Board of Directors voted to create the new positions of Vice Chairman and Lead Director. The Board, in the same May 16, 2014, meeting, then appointed N. Scott Fine to fill the new roles based on...

2014-05-15 23:13:46

The Company’s strong cash balance and cash flows position it for continued growth. Alachua, FL (PRWEB) May 15, 2014 CTD Holdings, Inc., a manufacturer of cyclodextrins, (OTCQB:CTDH) reported product sales of $560,325 for the first quarter ended March 31, 2014. The Trappsol(R) Cyclo(TM) orphan drug product generated first-quarter sales of $418,000, a 97% increase from the same period a year ago. Cash increased to $873,000 during the first quarter due to strong sales and $500,000 raised...

2014-04-16 23:07:54

Investment establishes a strategic relationship with the USP Group for product development and marketing and adds new board member. Alachua, FL (PRWEB) April 16, 2014 CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer and distributor of cyclodextrins for the pharmaceutical, medical device, cosmetics and other markets, announced today that it has closed on a Securities Purchase and Collaboration Agreement with Novit LP an affiliated entity of the USP Group, a major manufacturer and...

2014-04-14 23:05:25

Starch derivatives market report provides a comprehensive view of the industry’s drivers, restraints, opportunities, and key issues. (http://www.marketsandmarkets.com/Market-Reports/starch-derivatives-market-116279237.html) (PRWEB) April 14, 2014 The report, "Starch Derivatives Market By Type (Maltodextrin, Cyclodextrin, Glucose Syrup, Hydrolysates And, Modified Starch), By Application (Food & Beverage, Feed, Paper, Cosmetics, Pharmaceutical, Bioethanol And Other Industrial...

2014-04-07 12:33:29

DALLAS, April 7, 2014 /PRNewswire/ -- The report, "Starch Derivatives Market by Type (Maltodextrin, Cyclodextrin, Glucose Syrup, Hydrolysates and, Modified Starch), by Application (Food & Beverage, Feed, Paper, Cosmetics, Pharmaceutical, Bioethanol and Other Industrial Applications) - Global Trends & Forecast To 2019", is published by MarketsandMarkets. According to the report, the global Starch Derivatives Market is expected to reach $58.2 Billion by the year 2019....

2014-03-11 23:31:33

Trappsol(R) Cyclo(TM) sales drive a record year as development of designated orphan drug continues. Alachua, FL (PRWEB) March 11, 2014 CTD Holdings, Inc. (OTCQB:CTDH) reported record product sales of $1,693,335 for the fiscal year ended December 31, 2013, a 71% increase over 2012 product sales. This revenue growth was driven by sales of Trappsol products to existing and new customers. The Company reported net income of $205,000 for 2013, a 176% increase over 2012. Fiscal 2013 Highlights:...

2014-02-20 23:32:30

Investment to speed development of orphan drug, other corporate goals. Alachua, FL (PRWEB) February 20, 2014 CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer of cyclodextrins for the pharmaceutical and other markets, announced today that it has closed on a private placement of $500,000 with a group of seasoned international investors who are experienced in the consumer and healthcare industries. The investment is meant to help accelerate the development of the Company’s Trappsol(R)...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.